Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Keyword(s):
Phase Ii
◽
2006 ◽
Vol 1
(7)
◽
pp. 673-678
◽